Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
Published inBMC Infectious Diseases, vol. 17, no. 1, 476
Publication date2017
Abstract
Keywords
- Adult
- Anti-HIV Agents/therapeutic use
- Antiretroviral Therapy
- Highly Active/methods
- Benzoxazines/adverse effects
- CD4 Lymphocyte Count
- Drug Combinations
- Emtricitabine/therapeutic use
- Female
- HIV Infections/drug therapy
- HIV-1/genetics
- Humans
- Male
- Middle Aged
- Prospective Studies
- Rilpivirine/therapeutic use
- Tenofovir/therapeutic use
- Treatment Outcome
- Viral Load
Research group
Citation (ISO format)
SCULIER, Delphine et al. Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. In: BMC Infectious Diseases, 2017, vol. 17, n° 1, p. 476. doi: 10.1186/s12879-017-2579-2
Main files (1)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Identifiers
- PID : unige:112377
- DOI : 10.1186/s12879-017-2579-2
- PMID : 28683720
ISSN of the journal1471-2334